Caricamento...
The paradigm shift to an “open” model in drug development
The rising cost of healthcare, the rising cost for drug development, the patent cliff for Big pharma, shorter patent protection, decrease reimbursement, and the recession have made it more difficult for the pharmaceutical and biotechnology industry to develop drugs. Due to the unsustainable amount o...
Salvato in:
| Pubblicato in: | Appl Transl Genom |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888825/ https://ncbi.nlm.nih.gov/pubmed/27294020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atg.2014.09.001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|